Versigent PLC (VGNT) SEC Filings & Earnings Calls
EquiReason read 7 Versigent PLC SEC filings in the last 12 months. Latest: 10-Q on 2026-08-04 — Versigent completed its spin-off from Aptiv on April 1, 2026, becoming an independent publicly traded company..
Source: SEC EDGAR filings · read by EquiReason
- Market cap
- 2.9B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 4 Nov, in 10 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
4 Aug 202610-QVersigent completed its spin-off from Aptiv on April 1, 2026, becoming an independent publicly traded company.open
Figures in the filing · each found in the filing text
| Net sales · Q2-2026 | $2.44B | +11% y/y |
| Operating income · Q2-2026 | $199M | +52% y/y |
| Net income attributable to Versigent · Q2-2026 | $118M | +10% y/y |
| Cash and cash equivalents · 2026-06-30 | $554M | +101% y/y |
| Capital expenditures · H1-2026 | $117M | +48% y/y |
| Accounts receivable, net · 2026-06-30 | $1.88B | +20% y/y |
| Inventories · 2026-06-30 | $772M | 0% y/y |
| Total assets · 2026-06-30 | $5.36B | +19% y/y |
| Operating cash flow · H1-2026 | $194M | +2% y/y |
| Basic earnings per share · Q2-2026 | $1.66 | +10% y/y |
Risks flagged
Customer concentration risk
“Our ten largest customers accounted for approximately 83 % and 81 % of our total net sales for the three and six months ended June 30, 2026, respectively.” · word for word
Spin-off execution risk
“The historical financial information presented for periods prior to April 1, 2026 may not be indicative of the results of operations or financial position that would have been achieved if Versigent had been a stand-alone publicly-traded company” · word for word
High leverage post spin-off
“Short-term debt (Note 10) $ 153 $ 58 ... Long-term debt (Note 10) 2,071 3” · word for word
4 Aug 20268-K · 2.02Net Sales $2.44B (+11% y/y); Net income attributable to Versigent $118M (+10% y/y); Diluted Earnings Per Share $1.64; Guidance: Net sales guidance raised from $9.1-9.4B to $9.4-9.6Bearningsopen
Figures in the filing · each found in the filing text
| Net Sales · Consolidated · Q2-2026 | $2.44B | +11% y/y |
| Net income attributable to Versigent · Consolidated · Q2-2026 | $118M | +10% y/y |
| Diluted Earnings Per Share · Consolidated · Q2-2026 | $1.64 | |
| Adjusted Diluted EPS · Consolidated · Q2-2026 | $1.92 | |
| Adjusted EBITDA · Consolidated · Q2-2026 | $272M | +25% y/y |
| Adjusted EBITDA Margin · Consolidated · Q2-2026 | 11.1% | |
| Net cash provided by operating activities · Consolidated · Q2-2026 | $158M | +5% y/y |
| Free Cash Flow · Consolidated · Q2-2026 | $107M | 0% y/y |
| Capital Expenditures · Consolidated · Q2-2026 | $51M | +21% y/y |
Guidance
Net sales guidance raised from $9.1-9.4B to $9.4-9.6B
Guidance raise driven by higher commodity pass-throughs and FX; strong margin and cash flow performance.
Risks flagged
Higher interest expense from new debt issuance
“Interest expense totaled $36 million, compared to $1 million in the second quarter of 2025.” · word for word
Commodity cost headwinds
“Adjusted EBITDA margin reflected disciplined operating execution and higher volumes, despite headwinds related to commodity costs.”
5 May 202610-QNet sales $2.21B (+9% y/y); Net income attributable to Versigent $78M (-18% y/y); Operating cash flow $36M (-10% y/y)open
Figures in the filing · each found in the filing text
| Net sales · Q1-2026 | $2.21B | +9% y/y |
| Net income attributable to Versigent · Q1-2026 | $78M | -18% y/y |
| Operating cash flow · Q1-2026 | $36M | -10% y/y |
| Operating margin · Q1-2026 | 3.3% |
Risks flagged
Restructuring and separation cost overrun
“Restructuring $46M vs $16M; Separation costs $26M vs $5M in prior year period.”
Customer concentration risk
“Three customers each accounted for more than 10% of net sales at 18%, 17% and 13%.” · word for word
5 May 20268-K · 2.02Revenue $2.21B (+9% y/y); Net income attributable to Versigent $78M (-18% y/y); Adjusted EBITDA $203M (+2% y/y); Guidance: Revenue $9.1B-$9.4B; Adjusted EBITDA $950M-$1,030M; Free cash flow $200M-$300Mearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $2.21B | +9% y/y |
| Net income attributable to Versigent · Q1-2026 | $78M | -18% y/y |
| Adjusted EBITDA · Q1-2026 | $203M | +3% y/y |
| Adjusted EBITDA margin · Q1-2026 | 9.2% | |
| Cash from operations · Q1-2026 | $36M | -10% y/y |
| Free cash flow · Q1-2026 | $-30M | |
| Capital expenditures · Q1-2026 | $66M |
Guidance
Revenue $9.1B-$9.4B; Adjusted EBITDA $950M-$1,030M; Free cash flow $200M-$300M
Versigent reaffirmed its full-year 2026 guidance, indicating confidence in continued demand and operational execution.
Risks flagged
Commodity cost and foreign exchange headwinds could pressure margins.
“Adjusted EBITDA margin reflected disciplined operating execution and higher volumes, despite headwinds related to commodity costs and foreign exchange impacts.” · word for word
Separation costs and restructuring expenses impacting near-term free cash flow.
“Free cash flow was $(30) million... primarily driven by an increase in restructuring costs, one-time separation costs and capital expenditures” · word for word
1 Apr 20268-K · 1.01, 2.01, 2.03, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01Aptiv PLC completed spin-off of Versigent PLC, distributing shares pro rata to Aptiv shareholders. Versigent became an independent public company with $1.35B credit facilities and $1.6B senior notes.open
Figures in the filing · each found in the filing text
| Term Loan A Facility · Q1-2026 | $500M | |
| Revolving Credit Facility · Q1-2026 | $850M | |
| 2031 Notes · Q1-2026 | $800M | |
| 2034 Notes · Q1-2026 | $800M | |
| Ordinary shares issued to Aptiv · Q1-2026 | 70,892,660 |
Risks flagged
High leverage from $1.35B credit facilities and $1.6B senior notes may strain cash flows and increase refinancing risk.
“Credit facilities of $1.35B and senior notes of $1.6B issued, with interest rates of 6.125% and 6.375%.”
24 Mar 20268-K · 5.02Reported a director or officer change (departure, election, appointment or pay arrangement)open
Risks flagged
Spin-off execution risk; new board composition and governance transition.
“Spin-off from Aptiv expected April 1, 2026; board size increased from 2 to 3.”
12 Mar 20268-K · 7.01Issued a Regulation FD disclosure (forward guidance or material update); filed financial statements and exhibits with this reportopen
Risks flagged
Spin-off execution risk; tax-free treatment subject to conditions.
“subject to the satisfaction or waiver of certain conditions” · word for word
Versigent PLC — questions
- What did Versigent PLC file recently?
- 7 SEC filings in the last 12 months. Latest: 10-Q on 2026-08-04 — Versigent completed its spin-off from Aptiv on April 1, 2026, becoming an independent publicly traded company.
Every figure on this page comes from Versigent PLC's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.